Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates

PURPOSE: Within the last decade, SurePath and ThinPrep [both liquid-based cytology (LBC) tests] have replaced conventional cytology (CC) as primary test method in cervical cancer screening programs of multiple countries. The aim of our study was to examine the effect in the Dutch screening program....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Causes Control
Asıl Yazarlar: Rozemeijer, Kirsten, Penning, Corine, Siebers, Albert G., Naber, Steffie K., Matthijsse, Suzette M., van Ballegooijen, Marjolein, van Kemenade, Folkert J., de Kok, Inge M. C. M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2015
Konular:
Original Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4703623/
https://ncbi.nlm.nih.gov/pubmed/26458884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10552-015-0678-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller